MAP7 and ovarian cancer: Prognostic implications were further elucidated using the Kaplan–Meier Plotter, revealing a significant linkage between heightened MAP7 expression and diminished progression-free survival (PFS) and overall survival (OS) among ovarian cancer patients (Fig. 1D and E), thus underscoring the potential of MAP7 upregulation as an indicator of poor clinical outcome.